Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ingredion Inc has a consensus price target of $142.29 based on the ratings of 7 analysts. The high is $168 issued by Barclays on November 6, 2024. The low is $110 issued by Credit Suisse on February 9, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, UBS, and Oppenheimer on April 22, 2025, April 7, 2025, and February 5, 2025, respectively. With an average price target of $155.67 between Oppenheimer, UBS, and Oppenheimer, there's an implied 13.21% upside for Ingredion Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/22/2025 | Buy Now | 12.73% | Oppenheimer | Kristen Owen61% | $167 → $155 | Maintains | Outperform | Get Alert |
04/07/2025 | Buy Now | 5.45% | UBS | Cody Ross45% | $165 → $145 | Downgrade | Buy → Neutral | Get Alert |
02/05/2025 | Buy Now | 21.45% | Oppenheimer | Kristen Owen61% | $178 → $167 | Maintains | Outperform | Get Alert |
02/05/2025 | Buy Now | -3.27% | BMO Capital | Andrew Strelzik66% | $147 → $133 | Maintains | Market Perform | Get Alert |
02/05/2025 | Buy Now | 9.09% | Stephens & Co. | Ben Bienvenu75% | $155 → $150 | Maintains | Equal-Weight | Get Alert |
11/15/2024 | Buy Now | 25.82% | UBS | Cody Ross45% | $165 → $173 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 6.91% | BMO Capital | Andrew Strelzik66% | $128 → $147 | Maintains | Market Perform | Get Alert |
11/06/2024 | Buy Now | 22.18% | Barclays | Benjamin Theurer61% | $145 → $168 | Maintains | Overweight | Get Alert |
11/06/2024 | Buy Now | 29.45% | Oppenheimer | Kristen Owen61% | $147 → $178 | Maintains | Outperform | Get Alert |
10/21/2024 | Buy Now | 6.91% | Oppenheimer | Kristen Owen61% | $138 → $147 | Maintains | Outperform | Get Alert |
08/15/2024 | Buy Now | 7.64% | UBS | Cody Ross45% | $141 → $148 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 5.45% | Barclays | Benjamin Theurer61% | $122 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
08/07/2024 | Buy Now | -6.91% | BMO Capital | Andrew Strelzik66% | $120 → $128 | Maintains | Market Perform | Get Alert |
08/07/2024 | Buy Now | 0.36% | Oppenheimer | Kristen Owen61% | $126 → $138 | Maintains | Outperform | Get Alert |
05/09/2024 | Buy Now | -12.73% | BMO Capital | Andrew Strelzik66% | $117 → $120 | Maintains | Market Perform | Get Alert |
03/06/2024 | Buy Now | -11.27% | Barclays | Benjamin Theurer61% | $115 → $122 | Maintains | Equal-Weight | Get Alert |
02/16/2024 | Buy Now | -1.82% | Goldman Sachs | Adam Samuelson57% | $122 → $135 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | -1.82% | Goldman Sachs | Adam Samuelson57% | $122 → $135 | Upgrade | Neutral → Buy | Get Alert |
02/07/2024 | Buy Now | -5.45% | Stephens & Co. | Ben Bienvenu75% | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
11/13/2023 | Buy Now | -1.09% | UBS | Cody Ross45% | $132 → $136 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | -5.45% | Stephens & Co. | Ben Bienvenu75% | → $130 | Reiterates | Overweight → Overweight | Get Alert |
11/01/2023 | Buy Now | -20% | Barclays | Benjamin Theurer61% | $118 → $110 | Maintains | Equal-Weight | Get Alert |
09/29/2023 | Buy Now | -12.73% | Oppenheimer | Kristen Owen61% | → $120 | Initiates | → Outperform | Get Alert |
08/09/2023 | Buy Now | -14.91% | BMO Capital | Andrew Strelzik66% | $125 → $117 | Maintains | Market Perform | Get Alert |
08/09/2023 | Buy Now | -5.45% | Stephens & Co. | Ben Bienvenu75% | → $130 | Reiterates | Overweight → Overweight | Get Alert |
06/01/2023 | Buy Now | -14.18% | Barclays | Benjamin Theurer61% | $120 → $118 | Maintains | Equal-Weight | Get Alert |
05/04/2023 | Buy Now | -10.55% | BMO Capital | Andrew Strelzik66% | $115 → $123 | Maintains | Market Perform | Get Alert |
05/04/2023 | Buy Now | -5.45% | Stephens & Co. | Ben Bienvenu75% | $120 → $130 | Maintains | Overweight | Get Alert |
05/04/2023 | Buy Now | -12.73% | Barclays | Benjamin Theurer61% | $110 → $120 | Maintains | Equal-Weight | Get Alert |
04/14/2023 | Buy Now | -16.36% | BMO Capital | Andrew Strelzik66% | → $115 | Reinstates | → Market Perform | Get Alert |
04/13/2023 | Buy Now | -12% | UBS | Cody Ross45% | $105 → $121 | Upgrade | Neutral → Buy | Get Alert |
03/17/2023 | Buy Now | -12.73% | Stephens & Co. | Ben Bienvenu75% | → $120 | Reiterates | → Overweight | Get Alert |
02/09/2023 | Buy Now | -20% | Credit Suisse | Robert Moskow67% | $100 → $110 | Maintains | Neutral | Get Alert |
01/23/2023 | Buy Now | -20% | Barclays | Benjamin Theurer61% | → $110 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/17/2023 | Buy Now | -12.73% | Stephens & Co. | Ben Bienvenu75% | $100 → $120 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/07/2022 | Buy Now | -27.27% | Credit Suisse | Robert Moskow67% | $94 → $100 | Maintains | Neutral | Get Alert |
09/30/2022 | Buy Now | -35.27% | UBS | Cody Ross45% | → $89 | Initiates | → Neutral | Get Alert |
The latest price target for Ingredion (NYSE:INGR) was reported by Oppenheimer on April 22, 2025. The analyst firm set a price target for $155.00 expecting INGR to rise to within 12 months (a possible 12.73% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Ingredion (NYSE:INGR) was provided by Oppenheimer, and Ingredion maintained their outperform rating.
The last upgrade for Ingredion Inc happened on August 9, 2024 when Barclays raised their price target to $145. Barclays previously had an equal-weight for Ingredion Inc.
The last downgrade for Ingredion Inc happened on April 7, 2025 when UBS changed their price target from $165 to $145 for Ingredion Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingredion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingredion was filed on April 22, 2025 so you should expect the next rating to be made available sometime around April 22, 2026.
While ratings are subjective and will change, the latest Ingredion (INGR) rating was a maintained with a price target of $167.00 to $155.00. The current price Ingredion (INGR) is trading at is $137.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.